Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HSTO - Histogen Inc

Previous close
0.2225
0   0%

Share volume: 14,817
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$0.22
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
1.14%
1 Month
1.14%
3 Months
29.36%
6 Months
-29.37%
1 Year
-69.93%
2 Year
-69.93%
Key data
Stock price
$0.22
P/E Ratio 
-0.08
DAY RANGE
N/A - N/A
EPS 
-$2.89
52 WEEK RANGE
$0.10 - $0.93
52 WEEK CHANGE
-$0.70
MARKET CAP 
950.466 K
YIELD 
N/A
SHARES OUTSTANDING 
4.272 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$385
AVERAGE 30 VOLUME 
$1,059
Company detail
CEO: Steven Mento
Region: US
Website: https://www.conatuspharma.com/
Employees: 25
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor. two product families - a proprietary liquid complex of embryonic-like proteins and growth factors, and a human extracellular matrix (ecm) material, exceltrix.

Recent news